重度髌骨外侧关节面骨关节炎在内侧单髁膝关节置换术患者选择中的作用:平均随访10年
研究纳入170例内侧单髁膝关节置换术(UKA)患者,其中48例(28%)术中见重度髌骨外侧关节面骨关节炎(LFPOA,Outerbridge 3-4级),所有患者均行常规髌骨成形术。平均随访10年,两组生存率、膝关节活动度及患者报告结局均无显著差异;作者认为无症状的3或4级LFPOA并非内侧UKA的禁忌证。
要点
- 平均随访10年,无LFPOA组与LFPOA组生存时间无显著差异(17.2年 vs 18.0年,P=0.94)。
- 两组KOOS各亚量表、VR-12及Knee Society Score均无显著差异。
- 作者认为无症状的Outerbridge 3-4级LFPOA不是内侧UKA的禁忌证。
核心结论
- 平均随访10年,重度LFPOA患者与无LFPOA患者的内侧UKA生存率和功能结局相当。
- 这些长期结果提示,无症状的3或4级LFPOA不是内侧UKA的禁忌证。
研究设计与样本
- 共实施170例内侧UKA,其中122例(72%)无LFPOA,48例(28%)有重度LFPOA。
- 重度LFPOA定义为术中见髌骨外侧关节面软骨Outerbridge 3至4级损伤,所有患者均行常规髌骨成形术。
主要发现
- 无LFPOA组有4例、LFPOA组有2例需行全膝关节置换术。
- 平均生存时间无显著差异:无LFPOA组17.2年(95%CI:17至18) vs LFPOA组18.0年(95%CI:17至19),P=0.94。
- 平均随访10年,两组膝关节屈曲或伸直无显著差异。
- 无痛性髌股摩擦音见于LFPOA组7例和无LFPOA组21例。
- 两组VR-12 MCS、PCS、KOOS各亚量表及Knee Society Score均无显著差异。
关键数值与推荐
- 重度LFPOA定义为术中见髌骨外侧关节面软骨Outerbridge 3至4级损伤。
- 无LFPOA组平均生存时间17.2年(95%CI:17至18) vs LFPOA组18.0年(95%CI:17至19),P=0.94。
- KOOS ADL的PASS达标率:无LFPOA组80%(90/112) vs LFPOA组82%(36/44),P=0.68。
- KOOS Sport的PASS达标率:无LFPOA组82%(92/112) vs LFPOA组82%(36/44),P=0.87。
临床怎么用
- 作者认为,无症状的Outerbridge 3或4级LFPOA不是内侧UKA的禁忌证。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lateral facet patellar osteoarthritis (LFPOA) has been reported as a contraindication for medial unicompartmental (UKA). The purpose of this paper was to determine if severe LFPOA was related to lower survivorship and patient-reported outcomes following medial UKA. METHODS: A total of 170 medial UKAs were performed. Severe LFPOA was defined as Outerbridge grade 3 to 4 damage on the lateral facet cartilage surfaces of the patella as noted intraoperatively. There were 122 of 170 patients (72%) who had noLFPOA and 48 of 170 patients (28%) who had had severe LFPOA. A routine patelloplasty was performed in all patients. Patients completed the Veterans RAND 12-Item Health Survey (VR-12) Mental Component Score (MCS) and Physical Component Score (PCS), Knee Injury and Osteoarthritis Outcome Score (KOOS), and Knee Society Score. RESULTS: There were 4 patients in the noLFPOA group who required total knee arthroplasty and 2 in the LFPOA group. There was no significant difference in mean survival time: noLFPOA = 17.2 years [95% confidence interval (CI): 17 to 18] and LFPOA = 18.0 years [95% CI: 17 to 19] (P = .94). At mean follow-up of 10 years, there were no significant differences in knee flexion or extension. Patello-femoral crepitus without pain was noted in 7 patients who had LFPOA and 21 patients who had noLFPOA. There were no significant differences in VR-12 MCS, PCS, KOOS subscales, or Knee Society Score between groups. Patient acceptable symptom state (PASS) was achieved in 80% (90 of 112) for KOOS ADL in the noLFPOA group and 82% (36 of 44) in the LFPOA group (P = .68). PASS was achieved in 82% (92 of 112) for KOOS Sport in the noLFPOA group and 82% (36/44) in the LFPOA group (P = .87). CONCLUSION: At a mean of 10 years, patients who had LFPOA had equivalent survivorship and functional outcomes to patients who did not have LFPOA. These long-term results suggest that asymptomatic grade 3 or 4 LFPOA is not a contraindication to medial UKA.
引用
- Plancher KD, Briggs KK, Tucker EE, et al. The Role of Severe Lateral Facet Patellar Osteoarthritis in Patient Selection for Success of a Medial Unicompartmental Knee Arthroplasty: Mean Follow-Up of 10 Years. J Arthroplasty. 2023. PMID: 37230228. doi:10.1016/j.arth.2023.05.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。